RU2699789C1 - Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) - Google Patents
Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) Download PDFInfo
- Publication number
- RU2699789C1 RU2699789C1 RU2019106746A RU2019106746A RU2699789C1 RU 2699789 C1 RU2699789 C1 RU 2699789C1 RU 2019106746 A RU2019106746 A RU 2019106746A RU 2019106746 A RU2019106746 A RU 2019106746A RU 2699789 C1 RU2699789 C1 RU 2699789C1
- Authority
- RU
- Russia
- Prior art keywords
- dry extract
- nanocapsules
- muirapuama
- guar gum
- molecules
- Prior art date
Links
- 239000002088 nanocapsule Substances 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 241000340987 Ptychopetalum olacoides Species 0.000 title abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000725 suspension Substances 0.000 claims abstract description 10
- 229920002907 Guar gum Polymers 0.000 claims abstract description 8
- 239000000665 guar gum Substances 0.000 claims abstract description 8
- 229960002154 guar gum Drugs 0.000 claims abstract description 8
- 235000010417 guar gum Nutrition 0.000 claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 7
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 4
- 229930195729 fatty acid Natural products 0.000 claims abstract description 4
- 239000000194 fatty acid Substances 0.000 claims abstract description 4
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 4
- 235000013305 food Nutrition 0.000 claims abstract description 4
- 150000002148 esters Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- -1 glycerol ester Chemical class 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 1
- 239000003094 microcapsule Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 4
- 239000001793 Citric acid esters of mono and diglycerides of fatty acids Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2/00—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms
- C07C2/02—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons
- C07C2/04—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons by oligomerisation of well-defined unsaturated hydrocarbons without ring formation
- C07C2/06—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons by oligomerisation of well-defined unsaturated hydrocarbons without ring formation of alkenes, i.e. acyclic hydrocarbons having only one carbon-to-carbon double bond
- C07C2/08—Catalytic processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2/00—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms
- C07C2/02—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons
- C07C2/04—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons by oligomerisation of well-defined unsaturated hydrocarbons without ring formation
- C07C2/06—Preparation of hydrocarbons from hydrocarbons containing a smaller number of carbon atoms by addition between unsaturated hydrocarbons by oligomerisation of well-defined unsaturated hydrocarbons without ring formation of alkenes, i.e. acyclic hydrocarbons having only one carbon-to-carbon double bond
- C07C2/08—Catalytic processes
- C07C2/26—Catalytic processes with hydrides or organic compounds
- C07C2/32—Catalytic processes with hydrides or organic compounds as complexes, e.g. acetyl-acetonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
- B01D3/06—Flash distillation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
- B01D3/14—Fractional distillation or use of a fractionation or rectification column
- B01D3/141—Fractional distillation or use of a fractionation or rectification column where at least one distillation column contains at least one dividing wall
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C7/00—Purification; Separation; Use of additives
- C07C7/005—Processes comprising at least two steps in series
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C7/00—Purification; Separation; Use of additives
- C07C7/04—Purification; Separation; Use of additives by distillation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C7/00—Purification; Separation; Use of additives
- C07C7/10—Purification; Separation; Use of additives by extraction, i.e. purification or separation of liquid hydrocarbons with the aid of liquids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00094—Jackets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00162—Controlling or regulating processes controlling the pressure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00164—Controlling or regulating processes controlling the flow
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C11/00—Aliphatic unsaturated hydrocarbons
- C07C11/02—Alkenes
- C07C11/04—Ethylene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2521/00—Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
- C07C2521/02—Boron or aluminium; Oxides or hydroxides thereof
- C07C2521/04—Alumina
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2521/00—Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
- C07C2521/06—Silicon, titanium, zirconium or hafnium; Oxides or hydroxides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2523/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
- C07C2523/16—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
- C07C2523/24—Chromium, molybdenum or tungsten
- C07C2523/26—Chromium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2527/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- C07C2527/06—Halogens; Compounds thereof
- C07C2527/135—Compounds comprising a halogen and titanum, zirconium, hafnium, germanium, tin or lead
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2531/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- C07C2531/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- C07C2531/12—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
- C07C2531/14—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Изобретение относится к области нанотехнологии, медицины, фармакологии и пищевой промышленности.The invention relates to the field of nanotechnology, medicine, pharmacology and the food industry.
Ранее были известны способы получения микрокапсул.Previously known methods for producing microcapsules.
В пат. 2173140 МПК A61K 009/50, A61K 009/127 Российская Федерация опубликован 10.09.2001 предложен способ получения кремнийорганолипидных микрокапсул с использованием роторно-кавитационной установки, обладающей высокими сдвиговыми усилиями и мощными гидроакустическими явлениями звукового и ультразвукового диапазона для диспергирования.In US Pat. 2173140 IPC A61K 009/50, A61K 009/127 Russian Federation published September 10, 2001. A method for producing silicon-organolipid microcapsules using a rotary-cavitation unit with high shear forces and powerful sonar and ultrasonic sonar phenomena for dispersion is proposed.
Недостатком данного способа является применение специального оборудования - роторно-кавитационной установки, которая обладает ультразвуковым действием, что оказывает влияние на образование микрокапсул и при этом может вызывать побочные реакции в связи с тем, что ультразвук разрушающе действует на полимеры белковой природы, поэтому предложенный способ применим при работе с полимерами синтетического происхождения.The disadvantage of this method is the use of special equipment - a rotary cavitation unit, which has an ultrasonic effect, which affects the formation of microcapsules and can cause adverse reactions due to the fact that ultrasound destructively affects polymers of a protein nature, therefore, the proposed method is applicable when work with polymers of synthetic origin.
В пат. 2359662 МПК A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00 опубликован 27.06.2009 Российская Федерация предложен способ получения микрокапсул хлорида натрия с использованием распылительного охлаждения в распылительной градирне Niro при следующих условиях: температура воздуха на входе 10°С, температура воздуха на выходе 28°С, скорость вращения распыляющего барабана 10000 оборотов/мин. Микрокапсулы по изобретению обладают улучшенной стабильностью и обеспечивают регулируемое и/или пролонгированное высвобождение активного ингредиента.In US Pat. 2359662 IPC A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00 published on 06/27/2009 The Russian Federation proposed a method for producing sodium chloride microcapsules using spray cooling in a Niro spray cooling tower under the following conditions: inlet air temperature 10 ° C, outlet air temperature 28 ° C, the rotation speed of the spray drum 10,000 rpm. The microcapsules of the invention have improved stability and provide controlled and / or prolonged release of the active ingredient.
Недостатками предложенного способа являются длительность процесса и применение специального оборудования, комплекс определенных условий (температура воздуха на входе 10°С, температура воздуха на выходе 28°С, скорость вращения распыляющего барабана 10000 оборотов/мин).The disadvantages of the proposed method are the duration of the process and the use of special equipment, a set of certain conditions (air temperature at the inlet 10 ° C, air temperature at the outlet 28 ° C, rotation speed of the spray drum 10,000 rpm).
Наиболее близким методом является способ, предложенный в пат.2134967 МПК A01N 53/00, A01N 25/28 опубликован 27.08.1999 Российская Федерация (1999). В воде диспергируют раствор смеси природных липидов и пиретроидного инсектицида в весовом отношении 2-4:1 в органическом растворителе, что приводит к упрощению способа микрокапсулирования.The closest method is the method proposed in Pat.2134967 IPC A01N 53/00, A01N 25/28 published on 08.27.1999 Russian Federation (1999). A solution of a mixture of natural lipids and a pyrethroid insecticide in a weight ratio of 2-4: 1 in an organic solvent is dispersed in water, which simplifies the microencapsulation method.
Недостатком метода является диспергирование в водной среде, что делает предложенный способ неприменимым для получения микрокапсул водорастворимых препаратов в водорастворимых полимерах.The disadvantage of this method is dispersion in an aqueous medium, which makes the proposed method inapplicable for producing microcapsules of water-soluble preparations in water-soluble polymers.
Техническая задача - упрощение и ускорение процесса получения нанокапсул, уменьшение потерь при получении нанокапсул (увеличение выхода по массе).The technical task is to simplify and accelerate the process of obtaining nanocapsules, reduce losses in obtaining nanocapsules (increase in yield by mass).
Решение технической задачи достигается способом получения нанокапсул, отличающийся тем, что в качестве оболочки нанокапсул используется альгуаровая камедь, а в качестве ядра - сухой экстракт муира пуамы, при получении нанокапсул методом осаждения нерастворителем с применением фторбензола в качестве осадителя.The solution to the technical problem is achieved by the method of producing nanocapsules, characterized in that alguar gum is used as the shell of the nanocapsules, and dry extract of muira puama is used as the core when nanocapsules are prepared by the non-solvent precipitation method using fluorobenzene as the precipitant.
Отличительной особенностью предлагаемого метода является получение нанокапсул методом осаждения нерастворителем с использованием фторбензола в качестве осадителя, а также использование гуаровой камеди в качестве оболочки частиц и сухого экстракта муира пуамы - в качестве ядра.A distinctive feature of the proposed method is the preparation of nanocapsules by non-solvent deposition using fluorobenzene as a precipitant, as well as the use of guar gum as a particle shell and a dry extract of muira puama as a core.
Результатом предлагаемого метода являются получение нанокапсул сухого экстракта муиры пуамы.The result of the proposed method is the preparation of nanocapsules of dry extract of muira puama.
ПРИМЕР 1. Получение нанокапсул сухого экстракта муиры пуамы, соотношение ядро:оболочка 1:3.EXAMPLE 1. Obtaining nanocapsules of dry extract of muira puama, the ratio of core: shell 1: 3.
1,5 г сухого экстракта муиры пуамы добавляют в суспензию 4,5 г гуаровой камеди в этаноле в присутствии 0,01 г препарата Е472с (сложный эфир глицерина с одной-двумя молекулами пищевых жирных кислот и одной-двумя молекулами лимонной кислоты, причем лимонная кислота, как трехосновная, может быть этерифицирована другими глицеридами и как оксокислота - другими жирными кислотами. Свободные кислотные группы могут быть нейтрализованы натрием) в качестве поверхностно-активного вещества при перемешивании 900 об/мин. Далее приливают 8 мл фторбензола. Полученную суспензию отфильтровывают и сушат при комнатной температуре.1.5 g of a dry extract of Muira puama is added to a suspension of 4.5 g of guar gum in ethanol in the presence of 0.01 g of the preparation E472c (glycerol ester with one or two molecules of food fatty acids and one or two molecules of citric acid, with citric acid as tribasic, it can be esterified with other glycerides and as an acid with other fatty acids. Free acid groups can be neutralized with sodium) as a surfactant with stirring at 900 rpm. Then pour 8 ml of fluorobenzene. The resulting suspension is filtered and dried at room temperature.
Получено 6 г порошка нанокапсул. Выход составил 100%.Received 6 g of nanocapsule powder. The yield was 100%.
ПРИМЕР 2. Получение нанокапсул сухого экстракта муиры пуамы, соотношение ядро:оболочка 1:1.EXAMPLE 2. Obtaining nanocapsules of dry extract of muira puama, the ratio of core: shell 1: 1.
2 г сухого экстракта муиры пуамы добавляют в суспензию 2 г гуаровой камеди в этаноле в присутствии 0,01 г препарата Е472с в качестве поверхностно-активного вещества при перемешивании 900 об/мин. Далее приливают 8 мл фторбензола. Полученную суспензию отфильтровывают и сушат при комнатной температуре.2 g of dry extract of Muira puama is added to a suspension of 2 g of guar gum in ethanol in the presence of 0.01 g of the preparation E472c as a surfactant with stirring at 900 rpm. Then pour 8 ml of fluorobenzene. The resulting suspension is filtered and dried at room temperature.
Получено 4 г порошка нанокапсул. Выход составил 100%.Received 4 g of nanocapsule powder. The yield was 100%.
Пример 3 Получение нанокапсул сухого экстракта муиры пуамы, соотношение ядро:оболочка 1:2,Example 3 Obtaining nanocapsules of dry extract of muira puama, the ratio of core: shell 1: 2,
2 г сухого экстракта можжевельника добавляют в суспензию 4 г гуаровой камеди в этаноле в присутствии 0,01 г препарата Е472с в качестве поверхностно-активного вещества при перемешивании 900 об/мин. Далее приливают 8 мл фторбензола. Полученную суспензию отфильтровывают сушат при комнатной температуре.2 g of a dry extract of juniper is added to a suspension of 4 g of guar gum in ethanol in the presence of 0.01 g of the preparation E472c as a surfactant with stirring at 900 rpm. Then pour 8 ml of fluorobenzene. The resulting suspension is filtered off and dried at room temperature.
Получено 4 г порошка нанокапсул. Выход составил 100%.Received 4 g of nanocapsule powder. The yield was 100%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019106746A RU2699789C1 (en) | 2019-03-11 | 2019-03-11 | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2019106746A RU2699789C1 (en) | 2019-03-11 | 2019-03-11 | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2699789C1 true RU2699789C1 (en) | 2019-09-11 |
Family
ID=67989466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019106746A RU2699789C1 (en) | 2019-03-11 | 2019-03-11 | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2699789C1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2730847C1 (en) * | 2020-03-16 | 2020-08-26 | Александр Александрович Кролевец | Method of producing dry aloe extract nanocapsules |
| RU2744739C1 (en) * | 2020-06-25 | 2021-03-15 | Александр Александрович Кролевец | Method of obtaining nanocapusles of the dry boswellia extract |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2674660C1 (en) * | 2018-02-27 | 2018-12-12 | Александр Александрович Кролевец | Method of obtaining nanocapsules of dry extract of eucalyptus in guar gum |
-
2019
- 2019-03-11 RU RU2019106746A patent/RU2699789C1/en active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2674660C1 (en) * | 2018-02-27 | 2018-12-12 | Александр Александрович Кролевец | Method of obtaining nanocapsules of dry extract of eucalyptus in guar gum |
Non-Patent Citations (3)
| Title |
|---|
| B.V.N.Nagavarma. Different techniques for preparation of polymeric nanoparticles / Asian Journal Pharm Clin Res, 2012, vol.5, suppl. 3, pages 16-23. * |
| В.Д. Солодовник. Микрокапсулирование, 1980, стр.136-137. * |
| В.Д. Солодовник. Микрокапсулирование, 1980, стр.136-137. B.V.N.Nagavarma. Different techniques for preparation of polymeric nanoparticles / Asian Journal Pharm Clin Res, 2012, vol.5, suppl. 3, pages 16-23. * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2730847C1 (en) * | 2020-03-16 | 2020-08-26 | Александр Александрович Кролевец | Method of producing dry aloe extract nanocapsules |
| RU2744739C1 (en) * | 2020-06-25 | 2021-03-15 | Александр Александрович Кролевец | Method of obtaining nanocapusles of the dry boswellia extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2678973C1 (en) | Method for producing nanocapsules of dry extract of nettle | |
| RU2699791C1 (en) | Method for production of bergenia dry extract nanocapsules | |
| RU2705987C1 (en) | Method of producing boswellia dry extract nanocapsules | |
| RU2697839C1 (en) | Method of producing nanocapsules of a dry extract of propolis | |
| RU2714489C1 (en) | Method of producing nanocapsules of nettle dry extract | |
| RU2680805C1 (en) | Method for preparing nanocapsules of devil's-club dry extract in guar gum | |
| RU2680381C1 (en) | Method of obtaining dry milk thistle nanocapsules | |
| RU2681837C1 (en) | Method of producing dry extract of nanocapsules of propolis | |
| RU2696771C1 (en) | Method of producing nanocapsules of vitamin pp (nicolinamide) | |
| RU2699789C1 (en) | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) | |
| RU2657766C1 (en) | Method for producing rosemary nanocapules in carrageenan | |
| RU2674669C1 (en) | Method of obtaining nanocapsules of echinacea dry extract | |
| RU2677248C1 (en) | Method of obtaining nanocapsules of eucalyptus dry extract | |
| RU2708619C1 (en) | Method of producing nanocapsules of goldenrod dry extract (solidago canadensis) | |
| RU2680379C1 (en) | Method for obtaining dry extract nanocapsules of birch leaves | |
| RU2675803C1 (en) | Method of obtaining nanocapsules of dry extract of wild yams | |
| RU2680382C1 (en) | Method for obtaining dry extract nanocapsules of birch leaves | |
| RU2681842C1 (en) | Method of producing nanocapules of dry wormwood extract | |
| RU2695666C1 (en) | Method of producing nanocapsules of dry sage extract | |
| RU2677238C1 (en) | Method of obtaining nanocapsules for celandine dry extract of in guar gum | |
| RU2669356C1 (en) | Method for producing nanocapules of spirulin in guar gum | |
| RU2674652C1 (en) | Method of producing nanocapules of dry elecampane extract | |
| RU2674012C1 (en) | Method for preparing dry hedysarum extract nanocapsules in guar gum | |
| RU2699790C1 (en) | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) | |
| RU2714483C1 (en) | Method for producing nanocapsules of dry extract of muirapuama (ptychopetatum olacoides) |